Pioneer Fil-Med IPO

Pioneer Fil-Med Ltd. filed its DRHP with the Securities and Exchange Board of India (SEBI) on March 29, 2026, to raise funds through an Initial Public Offering (IPO). 

The company’s IPO is a book-built issue worth ₹500 crore. It includes a fresh issue of shares worth ₹250 crore, where the money raised will go to the company, and an Offer for Sale (OFS) of ₹250 crore, where existing shareholders will sell part of their holdings. 

The company plans to list its equity shares on both the NSE and BSE. Nuvama Wealth Management Ltd. is the book-running lead manager, which will manage the IPO process, while MUFG Intime India Pvt. Ltd. will act as the registrar, handling applications and allotment-related activities.

Pioneer Fil-Med IPO Important Dates

Yet to be announced

About Pioneer Fil-Med

Pioneer Fil-Med Limited is an Indian engineering and manufacturing company incorporated in 1997. The company manufactures filtration products such as air, oil and fuel filters, filter paper and specialised filter filaments. It also makes engineering components used in railways, defence, automobiles, power generation and heavy machinery. 

Its key products include brake discs for high-speed EMUs and metro systems, traction motor components, alternators and cylinder components. The company is also expanding its business into new areas, including railway and industrial gearboxes and components for wind generators, strengthening its presence in the renewable energy sector.

Pioneer Fil-Med has an annual operating revenue in the ₹100 crore–₹500 crore range, with recent filings indicating revenue of around ₹100–₹150 crore. Its authorised share capital is ₹35 crore, while its paid-up share capital stands at ₹25.53 crore. 

The company has its registered and corporate office in Nehru Place, New Delhi, with manufacturing operations and upcoming facilities in Gurugram, Haryana, and Salarpur, Bhiwadi, Rajasthan. Its customers and target markets include Indian Railways and metro networks, automotive manufacturers, defence companies, power generation businesses and renewable energy companies. The company is also planning new manufacturing facilities at its Salarpur location as part of its expansion plans.

Industry Outlook

The company operates in the capital goods manufacturing industry. 

1. India added 50,544 rolling stock units in FY25, up from 23,697 in FY20. Additions are projected to reach 2,04,011 units by FY30, implying a 32.2% CAGR during FY25–30. This can increase demand for Pioneer Fil-Med’s railway components, including traction motor parts, brake discs and other locomotive components.
2. Wagons accounted for 83% of rolling stock additions in FY25 and are projected to grow at a 35.2% CAGR during FY25–30. As Pioneer Fil-Med supplies components for railway applications, this expansion could provide opportunities to increase its presence in the wagon and freight segment.
3. Indian Railways’ capital expenditure has risen substantially, with ₹2.65 lakh crore allocated in FY25. Of this, ₹50,903 crore was earmarked for rolling stock, supporting procurement of locomotives, coaches and wagons.
4. The company’s traction motor components can benefit from continued railway electrification and fleet modernisation. Indian Railways added 1,472 locomotives and 6,550 coaches in FY24, alongside 37,650 wagons, indicating continued procurement of rolling stock.
5. Pioneer Fil-Med’s planned gearbox manufacturing facility could further position the company to participate in the growing railway and industrial equipment market, allowing it to broaden its product portfolio beyond its existing railway components.

Pioneer Fil-Med IPO Objectives

1. ₹114.41 crore will be used to part-finance the establishment of a gearbox manufacturing facility at Salarpur, Bhiwadi, Rajasthan, for industrial and railway applications.
2. ₹91.65 crore will be used to part-finance the establishment of a wind generator components manufacturing facility at Salarpur, Bhiwadi, Rajasthan.
3. Up to 25% of the gross IPO proceeds may be allocated towards general corporate purposes, including operational and administrative requirements.

The OFS portion of up to ₹250 crore will not accrue to the company. The proceeds will go to the selling shareholders, Pioneer Facor IT Infradevelopers Private Limited and Aztech India Private Limited.

Financial Performance of Pioneer Fil-Med 

Pioneer Fil-Med Peer Comparison

Strengths and Opportunities for Pioneer Fil-Med IPO

1. Pioneer Fil-Med has an established presence in the railway, metro and mobility components segment, supplying products such as traction motors, alternators, gangways, stators, rotors and platform screen doors.
2. Its diverse product portfolio serves diesel-electric and electric railway platforms, metro systems and automotive applications, helping reduce dependence on any single product or industry.
3. The company has a strong order book of ₹442 crore as of September 30, 2025, with around 91% linked to railway and metro projects, providing good revenue visibility.
4. Its financial performance has also strengthened, with revenue rising 40.11% in FY25 to ₹326.42 crore. The company reported an EBITDA margin of 23.89% in H1 FY26 and RoCE of 30.12% in FY25, indicating healthy operating profitability and capital efficiency.
5. The company has established manufacturing facilities in Bawal and Manesar, Haryana, giving it in-house production capabilities and greater control over manufacturing and quality.
6. Rising investments in railway electrification, rolling stock modernisation and metro infrastructure could create additional demand for the company’s railway and mobility components.
7. The company can also tap into the growing wind energy market by expanding its manufacturing capabilities for wind generator components, in line with India’s focus on renewable energy.
8. IPO proceeds are planned to support new gearbox and wind generator component manufacturing facilities at Salarpur, Bhiwadi, Rajasthan, enabling the company to expand capacity and address new sources of demand.
9. Government initiatives such as Make in India, local sourcing requirements and PLI schemes across sectors including defence, transportation and industrial manufacturing could further support demand for domestically manufactured components.

Risks and Threats for Pioneer Fil-Med IPO

1. The top 10 customers contributed 99.27% of revenue in H1 FY26, compared with 99.30% in FY25, 99.43% in FY24 and 97.79% in FY23. The loss or reduction in orders from even a few key customers could materially impact revenue and profitability.
2. A significant share of the company’s railway and metro business is secured through competitive bidding and tender processes. Changes in government policies, tender conditions, regulatory requirements or approval timelines could restrict its ability to qualify for and win new contracts.
3. The company’s order book is not necessarily indicative of future revenue or profits, as contracts may be delayed, modified, cancelled, suspended or remain partially unpaid. Consequently, the actual financial contribution from the reported order book could be substantially lower than expected.
4. A significant portion of revenue comes from repeat orders from existing customers, while the company generally does not have long-term or committed-volume agreements with most customers. Even established railway relationships do not guarantee future orders, creating visibility and revenue-continuity risks.
5. The company must accurately assess project requirements, raw-material costs, equipment costs and execution expenses before submitting bids. Any underestimation of project costs could compress margins or reduce expected returns, particularly in fixed-price contracts.
6. The wind generator business is still at an early stage and currently depends on a single customer. Any loss of this customer or significant decline in its demand could disproportionately affect the segment's revenue, profitability and cash flows.

Pioneer Fil-Med IPO Reservation

Pioneer Fil-Med IPO Promoter Holding

The company’s promoter group includes 4 corporate entities, along with Sushil Kumar Jain, Anil Kumar Agarwal, Rishabh Jain, Akshat Agarwal and Anita Jain. 

The 4 entities are as follows:

• Pioneer Facor IT Infradevelopers Pvt. Ltd.
• Pioneer Procon Pvt. Ltd.
• Pioneer Securities Pvt. Ltd
• Pioneer Fincap Pvt. Ltd

Note: Equity dilution will be determined by subtracting the Shareholding Post Issue from the Shareholding Pre Issue.

Pioneer Fil-Med IPO Registrar and Lead Managers

Pioneer Fil-Med IPO Lead Managers

1. Nuvama Wealth Management Ltd.
2. Equirus Capital Ltd.

Registrar for Pioneer Fil-Med IPO 

Name: MUFG Intime India Pvt.Ltd.

Phone: 022-49186000

Email ID: pioneerfilmed.ipo@in.mpms.mufg.com

How To Check the Allotment Status of the Pioneer Fil-Med IPO?

Steps to check IPO allotment status on Angel One’s app:

1. Log in to the Angel One app.
2. Go to the IPO Section and then to IPO Orders.
3. Select the individual IPO that you had applied for and check the allotment status.
4. Angel One will notify you of your IPO allotment status via push notification and email.

How To Apply for Pioneer Fil-Med IPO Online?

1. Login to Your Angel One Account: Open the Angel One app or website and log in with your credentials.
2. Locate the IPO Section: Navigate to the 'IPO' section on the platform.
3. Select IPO: Find and select the Pioneer Fil-Med IPO from the list of open IPOs.
4. Enter the Lot Size: Specify the number of lots you want to bid for.
5. Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
6. Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.

Contact Details of Pioneer Fil-Med IPO 

Address: 502 Padma Palace, 86 Nehru Place, New Delhi, New Delhi, 110019

Phone: 011-4563 8314

Email ID: cs@pioneerfilmed.com